Related Experiment Video
Updated: Jul 10, 2025

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
STAG2 Regulates Homologous Recombination Repair and Sensitivity to ATM Inhibition
Jie Zhou1,2, Run-Cong Nie3, Zhang-Ping He4
1State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Abstract:
Stromal antigen 2 (STAG2), a subunit of the cohesin complex, is recurrently mutated in various tumors. However, the role of STAG2 in DNA repair and its therapeutic implications are largely unknown. Here it is reported that knockout of STAG2 results in increased double-stranded breaks (DSBs) and chromosomal aberrations by reducing homologous recombination (HR) repair, and confers hypersensitivity to inhibitors of ataxia telangiectasia mutated (ATMi), Poly ADP Ribose Polymerase (PARPi), or the combination of both. Of note, the impaired HR by STAG2-deficiency is mainly attributed to the restored expression of KMT5A, which in turn methylates H4K20 (H4K20me0) to H4K20me1 and thereby decreases the recruitment of BRCA1-BARD1 to chromatin. Importantly, STAG2 expression correlates with poor prognosis of cancer patients. STAG2 is identified as an important regulator of HR and a potential therapeutic strategy for STAG2-mutant tumors is elucidated.
Insights
Stromal antigen 2 (STAG2) deficiency increases DNA damage by impairing homologous recombination (HR) repair. This finding reveals STAG2 as a potential therapeutic target for cancer treatment.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Stromal antigen 2 (STAG2) is a key component of the cohesin complex, frequently mutated in various cancers.
- The precise function of STAG2 in DNA repair pathways and its therapeutic relevance remain largely unexplored.
Purpose of the Study:
- To investigate the role of STAG2 in DNA repair mechanisms, specifically homologous recombination (HR).
- To explore the therapeutic implications of STAG2 deficiency in cancer treatment.
Main Methods:
- Gene knockout studies to assess the impact of STAG2 deficiency on DNA repair.
- Analysis of double-stranded breaks (DSBs) and chromosomal aberrations.
- Evaluation of sensitivity to DNA repair inhibitors (ATMi, PARPi).
- Chromatin immunoprecipitation assays to study protein recruitment.
Main Results:
- STAG2 knockout leads to increased DSBs and chromosomal aberrations due to reduced HR repair.
- STAG2-deficient cells exhibit hypersensitivity to ATMi and PARPi inhibitors.
- Impaired HR in STAG2-deficient cells is linked to KMT5A-mediated H4K20me1, which reduces BRCA1-BARD1 recruitment.
- Elevated STAG2 expression correlates with poor cancer patient prognosis.
Conclusions:
- STAG2 is a critical regulator of homologous recombination repair.
- Targeting STAG2-mutant tumors with DNA repair inhibitors presents a promising therapeutic strategy.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Homologous Recombination
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Restarting Stalled Replication Forks
Long-patch Base Excision Repair

